Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IntelliCell Biosciences Inc announces it will file an IND for Osteoarthritis of the Knee in conjunction with the Andrews's Research and Educational Foundation


Monday, 17 Mar 2014 09:24am EDT 

IntelliCell Biosciences Inc:Says it has signed consulting agreements with Dr Adam Anz and Dr Josh Hackel of the Andrews's Research and Education Foundation (AREF) in Gulf Breeze, Florida.Intellicell will be filing an IND for the treatment of osteoarthritis of knee lead by Dr. James Andrews and conducted by Drs. Anz and Hackel for its Stromal Vascular Fraction Cells (SVFC). 

Company Quote

0.0013
-1.0E-4 -7.14%
2:46pm EDT